Literature DB >> 2091795

Blood conservation.

A M Chavez1, D M Cosgrove.   

Abstract

The importance of blood conservation to minimize homologous blood use after cardiac surgery is well-accepted. The most successful programs to this end are the products of an integrated approach to blood conservation that begins with preoperative patient screening and carries through the postoperative period. Salvage and reinfusion of shed blood both intra- and postoperatively are important components of any such program. Other practices that help reduce blood loss and decrease the use of banked blood are also important. It is the combination of techniques and a consistent philosophy regarding the importance of blood conservation that will yield the best results. Programs that decrease the use of banked blood help today's cardiac surgeon provide safer, less costly operations for his or her patients.

Entities:  

Mesh:

Year:  1990        PMID: 2091795

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  4 in total

1.  Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minimizes blood loss and requirement during cardiac surgery.

Authors:  Shu Li; Hongwen Ji; Jing Lin; Eric Lenehan; Bingyang Ji; Jinping Liu; Jin Liu; Cun Long; Terry A Crane
Journal:  J Extra Corpor Technol       Date:  2005-03

2.  A survey of blood conservation methods in clinical practice in some urban south-eastern government hospitals in Nigeria.

Authors:  A O Amucheazi; V O Ajuzeiogu; H A Ezike; M C Odiakosa; O M Nwoke; E Onyia
Journal:  Asian J Transfus Sci       Date:  2011-01

3.  The use of an autologous fibrin sealant during a complex cardiac surgical procedure.

Authors:  Radosław Jarząbek; Paweł Bugajski; Krzysztof Greberski; Ryszard Kalawski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2018-03-28

4.  Autologous fibrin sealant application in cardiac surgery - a single-centre observational study.

Authors:  Radosław Jarząbek; Krzysztof Greberski; Paweł Bugajski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2021-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.